Arrow Financial’s GSK GSK Stock Holding History

Arrow Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-80	Closed	-$4K	–	350
2016 Q1	$4K	Sell	80 -152	-66%	-$7.57K	﹤0.01%	332
2015 Q4	$12K	Buy	232 +152	+190%	+$7.75K	﹤0.01%	286
2015 Q3	$4K	Sell	80 -80	-50%	-$4.16K	﹤0.01%	319
2015 Q2	$8K	Hold	160	–	–	﹤0.01%	287
2015 Q1	$10K	Hold	160	–	–	﹤0.01%	282
2014 Q4	$8K	Hold	160	–	–	﹤0.01%	298
2014 Q3	$10K	Hold	160	–	–	﹤0.01%	313
2014 Q2	$10K	Hold	160	–	–	﹤0.01%	285
2014 Q1	$10K	Hold	160	–	–	﹤0.01%	282
2013 Q4	$10K	Hold	160	–	–	﹤0.01%	264
2013 Q3	$10K	Hold	160	–	–	﹤0.01%	260
2013 Q2	$10K	Buy	+160	New	+$10.2K	﹤0.01%	252

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Arrow Financial's GSK Position: Q2 2016 in Review

Arrow Financial sold out of GSK (GSK) in Q2 2016, closing a stake of 80 shares — an estimated $4K sold.

Arrow Financial first reported a position in GSK in Q2 2013 and held it in 12 quarters. The position peaked at $12K in Q4 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

Arrow Financial reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
Arrow Financial sold 80 GSK shares in Q2 2016, an estimated $4K.
Arrow Financial first reported a position in GSK in Q2 2013 and held it in 12 quarters.
Arrow Financial's GSK position peaked at $12K in Q4 2015.
741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Arrow Financial's 13F filing for Q2 2016, filed 2 Aug 2016.